Exploring the Effect of Nice Guidelines on Prescribing for Childhood Atopic Eczema in Primary Care with An Interrupted Time Series
Introduction Atopic eczema (AE) is a chronic inflammatory skin condition affecting 20-32% of UK children, typically diagnosed and treated in primary care. National Institute of Health and Clinical Excellence (NICE, 2007) guidelines recommend all children presenting with AE in primary care are prescr...
主要な著者: | LIW Schreuders, SJ Ersser, C Thompson |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Swansea University
2020-12-01
|
シリーズ: | International Journal of Population Data Science |
オンライン・アクセス: | https://ijpds.org/article/view/1613 |
類似資料
-
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
著者:: Curtis, HJ, 等
出版事項: (2018) -
Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
著者:: Curtis, H, 等
出版事項: (2018) -
Management of Atopic Eczema in primary care
著者:: Ainol Haniza Kherul Anuwar, 等
出版事項: (2020-03-01) -
Parents' and carers' views about emollients for childhood eczema: qualitative interview study.
著者:: Santer, M, 等
出版事項: (2016) -
Childhood atopic eczema: children’s
Quality of life and family impact
著者:: Ghani, Ahmad Abir Ab
出版事項: (2012)